ABSTRACT Pulmonary arterial hypertension with severe pulmonarv vascular disease is a rare association of portal hypertension in man, be it the result of cirrhosis of the liver or obstruction of the portal vein. We induced portal hypertension in 23 rats by partially ligating the portal vein or by totally occluding it in two stages. The rats were killed between one and 15 months after operation. A collateral circulation of varicose, anastomotic vessels was established, and in six animals wellmarked oesophageal varices developed. Despite this evidence of sustained portal hypertension, hypertrophy did not develop in the right ventricle or in the media of the pulmonary trunk or muscular pulmonary arteries in any of the animals. This suggests that mechanical obstruction of the portal vein per se is not responsible for the development of pulmonary hypertension. Other factors, perhaps of a humoral nature, appear to be required to induce this rare association of portal hypertension but we have been unable to identify these. In particular, blood levels of oestrogen were not raised after ligation of the portal vein.
Very rarely cases of portal hypertension after cirrhosis of the liver or thrombosis of the portal vein in man become complicated by severe pulmonary arterial hypertension. The association was first reported by Mantz and Craige,' and a series of six such cases was described by Naeye.2 The elevation of pulmonary arterial blood pressure associated with portal hypertension is accompanied by the form of hypertensive pulmonary vascular disease designated "plexogenic pulmonary arteriopathy,"3 characterised by plexiform lesions whose nature and possible association with fibrinoid necrosis and pulmonary vasoconstriction we have described4 recently. Workers in our group have previously attempted to induce in rats pulmonary hypertension and associated pulmonary vascular disease by first inducing cirrhosis of the liver and portal hypertension.5 They successfully induced cirrhosis of the liver and portapulmonary venous anastomoses but not pulmonary arterial hypertension. From this it was concluded that an elevation of pulmonary arterial blood pressure is not produced by hepatic cirrhosis and portal hypertension per se but requires some additional factor which appears to develop only rarely in cases of cirrhosis of the liver. To support or refute this hypothesis we thought it would be of interest to see if experimental ligation of the portal vein always leads to pulmonary hypertension or whether, as in the case of hepatic cirrhosis, production of portal hypertension as a result of the local hepatic lesion is insufficient to induce pulmonary vascular disease and demands the addition of an as yet undetermined factor.
Methods
Two separate experimental techniques were employed to produce portal hypertension in rats. The first produced partial blockage of the portal vein whereas the second created a gradual but total occlusion of the vessel.
In the first experiment 33 adult Wistar Albino rats of both sexes were used. They were anaesthetised with ether and a midline incision made over the anterior third of the abdomen. The portal vein was isolated from its tethering fascia and a loop of grade 4/0 braided silk suture thread passed under the vessel close to the liver. A steel wire measuring 11 mm in diameter was then placed alongside the vessel and a suture tied firmly but not too tightly around both the 945 The blood plasma was assayed for the level of oestradiol using a radioimmunological method. The oestradiol in the plasma was labelled with 125. Antiserum to oestradiol was raised in the rabbit and added to the labelled plasma. The bound fraction was precipitated with polyethylene glycol and its level of radioactivity determined.
Results

MACROSCOPIC FINDINGS
In those rats which died a few hours after operation the portal vein and its tributaries proximal to the ligature were greatly dilated. The intestines were grossly congested and oedematous. The liver showed no abnormality apart from being slightly paler than normal. Death was attributed to the acute effects of portal vein ligation.10 11 In rats surviving longer than 24 hours but less than one week, death was caused in all but one case by rupture of collateral vessels in the omentum causing massive haemoperitoneum. In these animals the intestines and spleen were congested and the liver was pale with white patches of necrosis. Only onc animal died from sepsis of the operation site. The thoracic organs were normal. In animals which died after the double ligation procedure, death was also caused by rupture of collateral vessels in the omentum. In these animals congestion of the intestines and spleen was less severe.
In rats which survived longer than a week the necropsy findings were 
was often narrower than in the control rats. Most striking were numerous distended, often varicose collateral vessels in the omentum. These could be traced either directly to the liver or to the portal vein distal to the ligature thus bypassing the obstruction. Collateral vessels in the pleura could not be found but oesophageal varices were seen in six rats killed after 11 months, two after total ligation and four after partial ligation. All other organs were normal except for the spleen which was enlarged (table 1).
IHISTOLOGICAL FINDINGS
In rats which died prematurely the main hiistological feature was gross congestion of the intestines and spleen. In the intestine there was often associated haemorrhage within the submucosa. In the liver the hepatocytes were vacuolated with small foci of necrosis or occasional, larger infarcts. Vacuolation of hiepatocytes was also seen in rats with prolonged survival up to approximately two months, after which time the liver was identical to that in control rats. The histology of all other organs in the surviving rats from both groups was normal. Histological examination of the portal 
Discussion
There is no doubt that portal hypertension was induced in the test rats since the portal vein become engorged and an extensive collateral circulation was stimulated. It seems to us that venous collaterals play little or no part in these rare cases of pulmonary arterial hypertension complicating portal hypertension. In previous experiments from this laboratory in which cirrhosis of the liver was induced by the inhalation of carbon tetrachloride there was an extensive 
Golam Kibria, Paul Smith, Donald Heath, and Shanti Sagar mediastinal collateral system around the oesophagus with the formation of numerous portapulmonary venous anastomoses but there was no right ventricular hypertrophy or pulmonary vascular disease.5 While such portapulmonary venous anastomoses entering large pulmonary veins could readily account for the unsaturation of systemic arterial blood and cyanosis which sometimes occurs in cirrhosis of the liver, it is hard to see how an increased flow of blood entering the pulmonary circulation directly into the pulmonary veins could lead to plexogenic pulmonary arteriopathy, a form of vascular disease which in fact does not develop with raised pulmonary venous pressure. In the present experiments oesophageal vanices developed in six of the animals. In other rats the collateral vessels formed a direct anastomosis from the omentum either to the liver or to the portal vein distal to the ligature. Under these circumstances it is likely that, far from inducing pulmonary hypertension, such venous anastomoses may even have provided an adequate bypass to the portal vein thereby relieving the portal hypertension.
An alternative hypothesis to this mechanical explanation for the onset of severe pulmonary hypertension in rare cases of cirrhosis or portal vein obstruction is that a humoral mechanism is responsible. It is well known that certain substances which are toxic to the liver -will also produce pulmonary arterial hypertension in experimental animals. Examples are pyrrolizidine alkaloids such as monocrotaline,9 fulvine,'2 and senecionine.'3 In cirrhos,is or portal vein obstruction it is possible that dietary metabolites, which are normally detoxified by -the liver, bypass the liver, and find their way to the lungs. For example, the level of oestrogen in the blood is sometimes raised in cirrhosis. In our test animals we found that the ligation procedure did not lead to an elevation of oestrogen levels in the blood.
Occasionally in man, obstruction of the portal vein leads to nodules of adenomatous hyperplasia in the liver.14 15 In the latter case the obstruction was associated with fatal plexogenic pulmonary arteriopathy. It Hence we are faced with the fact that four rats surviving for 11 months after complete ligation of the portal vein and 11 rats surviving for a year or more after partial ligation of the vessel did not develop pulmonary hypertension. On the other hand we have recently reported a case where obstruction and recanalisation of the portal vein led to fatal pulmonary hypertension in a young man of 19 years.'5 One thing that is apparent from clinical studies is that cirrhosis of the liver is associated only very rarely with pulmonary hypertension. '7 In 12 years of practice at the Queen Elizabeth Hospital, Birmingham, one of us (DH) saw only one such case and in the next 11 years at Liver pool only the single case occurring in portal vein obstruction referred to above. During these 23 years many cases of cirrhosis of the liver were seen at necropsy. This may explain why we have failed to induce pulmonary hypertension in only 23 rats; perhaps a very large number of test animals may be required to induce it. It would appear that in cirrhosis of the liver or portal vein thrombosis, some added factor is needed to induce intense pulmonary vasoconstriction which in turn leads to plexogenic pulmonary arteriopathy, that form of pulmonary vascular disease which occurs in association with large congenital shunts or in primary pulmonary hypertension.
